AI-generated summary
The authors retrospectively reviewed medical records of 89 patients with meibomian gland dysfunction treated with intense pulsed-light using either a novel vascular filter or a conventional 590 nm filter. Both groups improved on symptom and gland measures after four treatments, with no significant between-group differences in those outcomes, though pain scores were lower with the conventional filter.
- Participants
- 89
- Who or what was studied
- Patients with meibomian gland dysfunction (89 patients, 89 eyes) who received intense pulsed-light treatment
- Wavelengths
- 530, 650, 900, 1200, 590 nm
- Limits stated in the abstract
- The study is a retrospective review of medical records comparing two groups, so the design cannot establish causation and the abstract does not describe randomization or a control arm.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
This study evaluates the effect of intense pulsed-light (IPL) treatment in patients with meibomian gland dysfunction (MGD) using a novel dual-band filter (vascular filter, 530-650 nm and 900-1200 nm) and compares it with the effect and discomfort during treatment using a conventional filter.
Methods
The medical records of 89 patients (89 eyes) with MGD who underwent IPL treatment were reviewed. Patients treated with the vascular filter or conventional 590 nm filter were designated as Group A or Group B, respectively. Patients underwent IPL treatment four times every four weeks. Ocular surface disease index (OSDI) scores, dry eye (DE), and MGD parameters were determined before the first IPL treatment and after the fourth IPL treatment. Visual analog scale (VAS) scores were obtained at every IPL treatment. OSDI, DE and MGD parameters, and VAS were compared between the groups.
Results
OSDI, DE, and MGD parameters improved after the four IPL treatments in both groups. There were no significant differences, between the groups, in OSDI, DE, and MGD parameters, before the first IPL treatment and after the fourth IPL treatment. VAS at each of the IPL treatments was lower in Group B than in Group A.
Conclusion
IPL treatment using the novel vascular filter for patients with MGD is effective compared with conventional IPL treatment for MGD patients.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 530-650 nm, 900-1200 nm, 590 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Visual analogue scale, Dry eye. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.